CN102824626A - 一种治疗过敏性鼻炎的药合泡剂及其制备方法 - Google Patents
一种治疗过敏性鼻炎的药合泡剂及其制备方法 Download PDFInfo
- Publication number
- CN102824626A CN102824626A CN2012103618721A CN201210361872A CN102824626A CN 102824626 A CN102824626 A CN 102824626A CN 2012103618721 A CN2012103618721 A CN 2012103618721A CN 201210361872 A CN201210361872 A CN 201210361872A CN 102824626 A CN102824626 A CN 102824626A
- Authority
- CN
- China
- Prior art keywords
- parts
- preparation
- medicine
- infusion
- soaking
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 48
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 229940079593 drug Drugs 0.000 title abstract description 10
- 206010039083 rhinitis Diseases 0.000 title abstract description 3
- 238000002791 soaking Methods 0.000 title abstract 6
- 230000002052 anaphylactic effect Effects 0.000 title abstract 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 19
- 239000011707 mineral Substances 0.000 claims abstract description 19
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000000052 vinegar Substances 0.000 claims abstract description 12
- 235000021419 vinegar Nutrition 0.000 claims abstract description 12
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 11
- 235000009566 rice Nutrition 0.000 claims abstract description 11
- 239000008187 granular material Substances 0.000 claims abstract description 9
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 5
- 238000001802 infusion Methods 0.000 claims description 20
- 206010039085 Rhinitis allergic Diseases 0.000 claims description 13
- 201000010105 allergic rhinitis Diseases 0.000 claims description 13
- 238000004140 cleaning Methods 0.000 claims description 11
- 239000008399 tap water Substances 0.000 claims description 6
- 235000020679 tap water Nutrition 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 239000011521 glass Substances 0.000 claims description 5
- 230000000149 penetrating effect Effects 0.000 claims description 5
- 238000003860 storage Methods 0.000 claims description 5
- 238000009423 ventilation Methods 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 4
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims description 4
- 238000012216 screening Methods 0.000 claims description 4
- 235000021022 fresh fruits Nutrition 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 102100037205 Sal-like protein 2 Human genes 0.000 claims description 2
- 101710192308 Sal-like protein 2 Proteins 0.000 claims description 2
- 241000209094 Oryza Species 0.000 claims 2
- 239000002552 dosage form Substances 0.000 claims 1
- 239000006260 foam Substances 0.000 claims 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract description 16
- 235000008397 ginger Nutrition 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 13
- 210000004369 blood Anatomy 0.000 abstract description 10
- 239000008280 blood Substances 0.000 abstract description 10
- 240000007594 Oryza sativa Species 0.000 abstract description 9
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 230000006870 function Effects 0.000 abstract description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 6
- 206010022000 influenza Diseases 0.000 abstract description 6
- 208000026435 phlegm Diseases 0.000 abstract description 6
- 208000024891 symptom Diseases 0.000 abstract description 6
- 230000029087 digestion Effects 0.000 abstract description 5
- 208000002193 Pain Diseases 0.000 abstract description 3
- 201000007100 Pharyngitis Diseases 0.000 abstract description 3
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 230000004089 microcirculation Effects 0.000 abstract description 3
- 230000036407 pain Effects 0.000 abstract description 3
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract description 2
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract description 2
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract description 2
- 230000003014 reinforcing effect Effects 0.000 abstract description 2
- 150000003839 salts Chemical class 0.000 abstract description 2
- 240000007906 Aidia cochinchinensis Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 235000002568 Capsicum frutescens Nutrition 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 230000000249 desinfective effect Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- 241000234314 Zingiber Species 0.000 description 15
- 239000000463 material Substances 0.000 description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 208000008454 Hyperhidrosis Diseases 0.000 description 8
- 208000013219 diaphoresis Diseases 0.000 description 8
- 238000001035 drying Methods 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 6
- 206010039101 Rhinorrhoea Diseases 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000036528 appetite Effects 0.000 description 5
- 235000019789 appetite Nutrition 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 235000013527 bean curd Nutrition 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 230000036737 immune function Effects 0.000 description 4
- 230000001788 irregular Effects 0.000 description 4
- 238000000465 moulding Methods 0.000 description 4
- 208000010753 nasal discharge Diseases 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010028748 Nasal obstruction Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000015111 chews Nutrition 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 235000011194 food seasoning agent Nutrition 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 210000002345 respiratory system Anatomy 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- GTLGHKNKLRZSMO-UHFFFAOYSA-N 4-(3-hydroxybutyl)-2-methoxyphenol Chemical compound COC1=CC(CCC(C)O)=CC=C1O GTLGHKNKLRZSMO-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- 101000740206 Mus musculus Sal-like protein 1 Proteins 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001989 choleretic effect Effects 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 210000002850 nasal mucosa Anatomy 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- 238000009461 vacuum packaging Methods 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 244000235603 Acacia catechu Species 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical group CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000009084 Cold Injury Diseases 0.000 description 1
- 235000017159 Crataegus pinnatifida Nutrition 0.000 description 1
- 241000657480 Crataegus pinnatifida Species 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000371997 Eriocheir sinensis Species 0.000 description 1
- 244000166124 Eucalyptus globulus Species 0.000 description 1
- 235000004692 Eucalyptus globulus Nutrition 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 102000011145 Hydroxysteroid Dehydrogenases Human genes 0.000 description 1
- 108010062875 Hydroxysteroid Dehydrogenases Proteins 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 208000000592 Nasal Polyps Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 101710202017 Protein 1.4 Proteins 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 231100000643 Substance intoxication Toxicity 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 244000274883 Urtica dioica Species 0.000 description 1
- 235000009108 Urtica dioica Nutrition 0.000 description 1
- 208000001407 Vascular Headaches Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 208000028004 allergic respiratory disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- -1 catechu naphthols Chemical class 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000731 choleretic agent Substances 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 230000002595 cold damage Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000003001 depressive effect Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- 201000003152 motion sickness Diseases 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000016366 nasal cavity polyp Diseases 0.000 description 1
- 239000007923 nasal drop Substances 0.000 description 1
- 230000004719 natural immunity Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000019617 piquancy Nutrition 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 208000037921 secondary disease Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000003519 ventilatory effect Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 208000016254 weariness Diseases 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗过敏性鼻炎的药合泡剂及其制备方法。这种药剂包括以下重量份数的药合泡物:红枣5~10、生姜20~50、辣椒1~5、当归0~10、食盐2~10、薄荷0~10、山黄皮果1~5,米醋为上述药合物总重量份数的0.3~1倍,矿泉水为药合物的0.1~0.5倍。所述的合泡剂,包括泡剂、片剂或颗粒剂,优选泡剂。本药剂采用安全无毒副作用的原料,配套科学的服用方法,药物直达病灶,解毒杀菌、活血化痰、疏通微循环、顺气去寒、发汗消热。药剂起效快,标本兼治,增进食欲、增强机体免疫功能。本药剂还可治咽炎、流行性感冒,舒解糖尿病患者身体疲软之苦。本药剂成本低,疗效好。
Description
技术领域
本发明涉及药品领域,具体涉及一种治疗过敏性鼻炎的药合泡剂及其制备方法。
背景技术
过敏性鼻炎是一种常见的多发病,人类患病率可达15--30%,患者年龄段不定,它在临床上定义为鼻粘膜接触过敏原后,由IGE介导的炎症反应引发的一系列鼻部症状如流涕、鼻塞、鼻痒、打喷嚏等,涉及面广,可伴有呼吸道变态反应病史,可并发鼻息肉、支气管哮喘、鼻出血、嗅觉障碍等继发病症,症状容易反复发作。
目前治疗过敏性鼻炎有的用抗生素、激素类,有的滴鼻剂处置等,有的用中药处置,往往疗程较长,用药量大,治愈率较低。是药三分毒,药物长期使用副作用大,易引起鼻腔粘膜病变。人的免疫功能是动态变化,一但经受寒热错杂变化,特别是体格消瘦的人员遇到低温天气,流涕、鼻塞、鼻痒、打喷嚏症状又会出现,不能明显根治。目前,中西医对过敏性鼻炎仍无疗效确切的药物。
发明内容
本发明的目的:提供一种解毒杀菌、活血化痰、疏通微循环、顺气去寒、发汗消热、增进食欲、增强机体免疫功能、治愈率高的治疗过敏性鼻炎药合泡剂及其制备方法。
本发明的技术方案是这样:
过敏性鼻炎是由于肺虚卫气失固,抵御外邪的能力下降,风寒乘虚而入所至,或因郁热内蕴、阴阳失调、寒热交替错杂所致。起初风热寒杂乱,气血失调;病久肺气阻塞气血不通,脉络阻滞,免疫功能下降,气汗失固,外邪耗伤阴血,清涕失禁,精气劳损,导致气血亏虚,怕冷。根据医学辨正原理,采用民间奇药妙方,选用对过敏性鼻炎具有特效的解毒、化痰、促进血液循环,发汗、去寒、健胃、消食、顺气、促进新陈代谢,提高人体免疫功能,增强抗病能力的日常食用原料,制备出方便治疗、效果好、无副作用的鼻炎制剂,配套科学的使用方法,使人体恢复到自然免疫健康状态。
以下是本发明治疗过敏性鼻炎的药物配方原料的药理药性。
红枣:含有大量的糖类物质,主要为葡萄糖,也含有果糖、蔗糖,以及由葡萄糖和果糖组成的低聚糖、阿拉伯聚糖及半乳醛聚糖等;并含有大量的维生素C、核黄素、硫胺素、胡萝卜素、尼克酸等多种维生素。现代的药理学则发现,红枣含有蛋白质、脂肪、醣类、有机酸、维生素A、维生素C、微量钙多种氨基酸等丰富的营养成份。具有较强的补养作用,能提高人体免疫功能,增强抗病能力,能促进白细胞的生成,降低血清胆固醇,提高血清蛋白,保护肝脏,大枣含多种类化合物,其中烨木酸、山植酸均发现有抗癌活性,对肉瘤S-180有抑制作用,甚至可使癌细胞向正常细胞转化的物质,有保肝、抗变态反应、安神、镇静之功,增强肌力和增加体重的作用。
生姜:成分含有辛辣和芳香成分。辛辣成分为一种芳香性挥发油脂中的"姜油酮"。其中主要为姜油萜、水茴香、樟脑萜、姜酚、桉叶油精、淀粉、粘液等。除含有姜油酮、姜油酚、姜油以外,还含有蛋白质1.4%、糖8%、脂肪0.7%。此外还有人体所必须的钙、磷、铁、胡萝卜素、硫胺素、核黄素、尼克酸、抗坏血栓和无机盐等营养成分。生姜能刺激胃粘膜,有温暖、兴奋、发汗、止呕、解毒等作用,特别对于鱼蟹毒、半夏、天南星等药物中毒有解毒作用。适用于外感风寒、头痛、痰饮、咳嗽、胃寒呕吐;在遭受冰雪、水湿、寒冷侵袭后,姜汤饮之,可增进血行,驱散寒邪。具有健胃、止血、顺气去寒、化痰解毒、发汗消热、调味蔬菜、增进食欲等功能。
辣椒:含有丰富的维生素A、维生素B族、维生素C等,其中的膳食纤维、矿物质也很丰富。功能有开胃消食,辣椒能促进消化液分泌,增进食欲,这时适当吃点辣椒,能让人食欲大振。暖胃驱寒,《食物本草》中说辣椒“消宿食,解结气,开胃门、辟邪恶、杀腥气诸毒”。它能促进血液循环,《药性考》中说辣椒能“温中散寒,除风发汗,去冷癖,行痰,祛湿。”辣椒能促进血液循环,改善怕冷、冻伤、血管性头疼。辣椒含有丰富的维生素C,同时还能促进荷尔蒙分泌。辣椒含丰富的膳食纤维,所以降血脂的作用也很明显,并有一定的抗癌作用。辣椒辛温,能够通过发汗而降低体温,并缓解肌肉疼痛,因此具有较强的解热镇痛作用。
当归:补血活血,止痛,润肠通便。用于血虚萎黄,眩晕心悸,虚寒腹痛,肠燥便秘。
米醋:消除疲劳,促进睡眠,并能减轻晕车、晕船的不适症状,调解血液的酸碱平衡,帮助消化,利于吸收。醋还有使鸡骨、鱼刺等骨刺软化的作用,从而促进钙的吸收,能帮助人有效的摄入钙质。增强肝脏、增强肾功能,扩张血管,防止心血管疾病、糖尿病的发生。有很好的抑菌和杀菌作用,增强肠胃道的杀菌能力,能有效预防肠道疾病、流行性感冒和呼吸疾病。
食盐:盐分子吸入体内能净化肺部,消毒、杀菌、驱寒等疗效。可以促进人体的血液循环,改善情绪波动、抑郁情绪、慢性疲劳,缓解精神紧张状况等。
薄荷:主要含荨荷脑、薄荷酮等挥发油成分。 薄荷醇能刺激皮肤神经末梢感受器,先产生凉的感觉。缓慢地透人皮内,引起长时间的充血,而达到治疗作用。有清凉、止痒、消炎、止痛的功效。薄荷能兴奋中枢神经,使周围毛细血管扩张而散热;并促进汗腺分泌而发汗。薄荷所含的8种儿茶萘酚酸是有效的抗炎剂,能抑制3a一羟类固醇脱氢酶而有抗炎作用。薄荷所含的蓝香油烃对烫伤有抗炎作用。薄荷能增加呼吸道黏液的分泌。祛除了附着于黏膜上的黏液,能减少泡沫痰,使呼吸道的有效通气量增大。薄荷油有健胃作用,对实验性胃溃疡有治疗作用;有较强的利胆作用,还有保肝作用。薄荷入茶饮,可以健胃祛风、祛痰、利胆、抗痉挛,改善感冐发烧、咽喉、肿痛,并消除头痛、牙痛、恶心感,及皮肤搔痒、腹部胀气、腹泻、消化不良、便秘丢等症状,且可缓和头痛,促进新陈代谢,对于呼吸道的发炎症状有治疗作用;能提振精神、使身心欢愉、帮助入眠。
山黄皮果:含有17种氨基酸,总含量为99.21mg/100g,蛋白质1.39%,总糖量为9.3%,维生素C74 mg/100g,总固形物17.5/%,总酸度为2.28%,可食率75%,还有人体需要的多种矿物营养。山黄果实、树叶均具有特殊香味,具消暑、消炎、化滞、祛湿、健脾健胃的功效,可鲜食、调味、入药,是食用和调味的上品和上佳的绿色保健食品 。《云南中草药选》:疏风解表,行气止痛,截疟,杀虫。治上感,流感,疟疾,腹痛。
本发明是这样实现的,包括以下重量份数的药合泡物:红枣5~10、生姜20~50、辣椒1~5、当归0~10、食盐2~10、薄荷0~10、山黄皮果1~5,米醋为上述药合物总重量份数的0.3~1倍,矿泉水为药合物的0.1~0.5倍。
以上所述的合泡剂,包括泡剂、片剂或颗粒剂,优选泡剂。
本发明提供的药合泡剂的制备方法,包括以下步骤。
1、泡剂的制备工艺步骤包括。
(1)筛选:生姜采用新鲜嫩姜(一般每年的8-10月采挖),辣椒、薄荷和山黄皮果采用新鲜或晒干的原料,红枣和当归采用干品,将上述原料分别筛选,将次品和霉变原料剔除,清徐杂物。
(2)自来水水洗:嫩姜通过人工或清洗机把表皮的泥土和腐皮彻底洗净,上述其它原料分别放入清洗池中清除杂物。红枣和当归待后清洗。
(3)矿泉水泡洗:将水洗过的原料再用矿泉水池泡5分钟,洗干净。
(4)嫩姜切块:用切刀或模具刀将嫩姜切成厚6-10毫米、重约5克、规则或不规则的块状。
(5)药合泡:将切好的姜块及时与辣椒、食盐、薄荷、山黄皮果、米醋、矿泉水放入瓷缸或玻璃缸密封合泡30-40天,然后将洗净的红枣和当归放入再合泡30-40天,存放环境需通风透光。
(6)分装:将泡好的姜块50克与10克泡液装入袋中,真空包装。
2、片剂、颗粒剂制备工艺步骤包括。
(1)筛选:生姜采用新鲜嫩姜(一般每年的8-10月采挖),辣椒、薄荷和山黄皮果采用新鲜或晒干的原料,红枣和当归采用干品,将上述原料分别筛选,将次品和霉变原料剔除,清徐杂物。
(2)自来水水洗:嫩姜通过人工或清洗机把表皮的泥土和腐皮彻底洗净,上述其它原料分别放入清洗池中清除杂物。红枣和当归待后清洗。
(3)矿泉水泡洗:将水洗过的原料再用矿泉水池泡5分钟,洗干净。
(4)嫩姜切块:用切刀或模具刀将嫩姜切成厚6-10毫米、重约5克、规则或不规则的块状。
(5)药合泡:将切好的姜块及时与辣椒、食盐、薄荷、山黄皮果、米醋、矿泉水放入瓷缸或玻璃缸密封合泡30-40天,然后将洗净的红枣和当归放入再合泡30-40天,存放环境通风透光。
(6)将经合泡好的姜块、薄荷、山黄皮果、红枣和当归原料药滤干,放入热风循环烘箱内烘干,温度控制在50—65℃,烘干时间1—10h,原料药水分含量≤20%。然后干燥粉碎,按常规成型方法造粒或制片型剂,颗粒剂每袋装散剂重量为5-8克,片剂每片1.5-2克。
本发明还提供上述药剂的使用方法事项:本发明药剂宜在饭后服用,尽可能让药剂长时间停留在咽喉部位,细嚼慢咽,服用过后30—60分钟内忌食其它一切食物。
本发明的优点和积极效果:本药剂采用原料安全无毒副作用,药物直达病灶,解毒杀菌、活血化痰、疏通微循环、顺气去寒、发汗消热。
本药剂起效快,治愈率高,标本兼治,增进食欲、增强机体免疫功能。
本药剂还可治咽炎、流行性感冒,舒解糖尿病患者身体疲软之苦。
本药剂成本低廉,疗效好。
具体实施方式
实施例1。泡剂的制备药物重量份数为:红枣5、生姜50、辣椒1、当归1、食盐3、薄荷1、山黄皮果鲜果2,米醋40,矿泉水10。
制备方法:将新鲜嫩姜放入清洗池中清除杂物,通过人工或清洗机把表皮的泥土和腐皮用自来水彻底洗净,新鲜或晒干的辣椒、薄荷和山黄皮果分别筛选,将次品和霉变原料剔除,清徐杂物。用切刀或模具刀将嫩姜切成厚6-10毫米、重约5克、规则或不规则的块状。将水洗过的原料再用矿泉水池泡5分钟,洗净滤干。然后将切好的姜块及时与辣椒、食盐、薄荷、山黄皮果、米醋、矿泉水一起放入瓷缸或玻璃缸密封合泡30-40天,然后将洗净的红枣和当归放入再合泡30-40天,存放环境通风透光。然后将泡好的姜块按50克与10克泡液装入袋中,真空包装。
泡剂的使用方法事项:药剂宜在饭后食用,细嚼慢咽,尽可能让药剂长时间停留在咽喉部位,食用过后30—60分钟内忌食其它一切食物。
实施例2:片剂、颗粒剂的制备药物重量份数为:红枣10、生姜50、辣椒1、当归2、食盐3、薄荷3、山黄皮果鲜果3,米醋40,矿泉水10。
制备方法:将新鲜嫩姜放入清洗池中清除杂物,通过人工或清洗机把表皮的泥土和腐皮用自来水彻底洗净,新鲜或晒干的辣椒、薄荷和山黄皮果分别筛选,将次品和霉变原料剔除,清徐杂物并用水清洗。用切刀或模具刀将嫩姜切成厚6-10毫米、重约5克、规则或不规则的块状。将水洗过的原料再用矿泉水池泡5分钟,洗净滤干。然后将切好的姜块及时与辣椒、食盐、薄荷、山黄皮果、米醋、矿泉水一起放入瓷缸或玻璃缸密封合泡30-40天,然后将洗净的红枣和当归放入再合泡30-40天,存放环境通风透光。然后将经合泡好的姜块、薄荷、山黄皮果、红枣和当归原料药滤干,放入热风循环烘箱内烘干,温度控制在50—65℃,烘干时间1—10h,原料药水分含量≤20%。然后干燥粉碎,按常规成型方法造粒或制片型剂,颗粒剂每袋装散剂重量为5-8克,片剂每片1.5-2克。
片剂、颗粒剂的使用方法事项:药剂宜在饭后食用,细嚼慢咽,尽可能让药剂长时间停留在咽喉部位,食用过后30—60分钟内忌食其它一切食物。
治疗实施例。
治疗对象:玉某,男,45岁,患者3年来反复发作性鼻塞,每逢风寒或喝酒后流清涕,每天早上起床鼻痒喷嚏不止,易感冒怕冷,精神疲乏,鼻粘膜苍白,诊为过敏性鼻炎。服用本发明的泡剂,第二天喷嚏减少;第三天鼻孔干透,精神舒爽;一周痊愈。
治疗对象:吴某,女,17岁,患者感风寒,咳嗽流涕3天,喉咙干涩,精神疲乏,诊为感冒。服用本发明的泡剂2天痊愈。
治疗对象:英某,女,65岁,患者带糖尿病,劳累风寒,感冒,精神疲倦无力,执西药效果不佳。服用本发明的泡剂1天,神气轻松,服用2天风感痊愈。
Claims (5)
1.一种治疗过敏性鼻炎的药合泡剂,其特征在于:包括以下药合泡物原料成分和重量份数:红枣5~10、生姜20~50、辣椒1~5、当归0~10、食盐2~10、薄荷0~10、山黄皮果鲜果1~5,米醋为上述药合剂总重量份数的0.3~1倍,矿泉水为药合物的0.1~0.5倍。
2.所述的药合泡剂的剂型,包括泡剂、片剂或颗粒剂,优选泡剂。
3.根据权利要求1所述及治疗过敏性鼻炎的药合泡剂制备方法,其特征在于:泡剂的制备工艺步骤包括筛选、自来水水洗、矿泉水泡洗、切块、合泡、分装、外包装。
4.根据权利要求1所述及治疗过敏性鼻炎的药合泡剂制备方法,其特征在于:片剂、颗粒剂制备工艺步骤包括筛选、自来水水洗、矿泉水泡洗、切块、合泡、滤干、烘干、粉碎,按常规成型方法造粒或制片型剂,分装。
5.根据权利要求3、4所述制备方法的合泡方法,其特征在于:将切好的姜块及时与辣椒、食盐、薄荷、山黄皮果、米醋、矿泉水一起放入瓷缸或玻璃缸密封合泡30-40天,然后将洗净的红枣和当归放入再合泡30-40天,存放环境通风透光。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012103618721A CN102824626A (zh) | 2012-09-26 | 2012-09-26 | 一种治疗过敏性鼻炎的药合泡剂及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012103618721A CN102824626A (zh) | 2012-09-26 | 2012-09-26 | 一种治疗过敏性鼻炎的药合泡剂及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102824626A true CN102824626A (zh) | 2012-12-19 |
Family
ID=47328072
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012103618721A Pending CN102824626A (zh) | 2012-09-26 | 2012-09-26 | 一种治疗过敏性鼻炎的药合泡剂及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102824626A (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103495144A (zh) * | 2013-10-12 | 2014-01-08 | 龚卫新 | 一种治疗过敏性鼻炎药剂 |
| CN106110248A (zh) * | 2016-07-15 | 2016-11-16 | 杨小玲 | 一种专治感冒、鼻炎的中草药 |
| CN107114795A (zh) * | 2017-07-06 | 2017-09-01 | 胥永贵 | 一种弱碱补钙、苏打碱化姜制剂及其制备方法和应用 |
| CN108355051A (zh) * | 2018-05-23 | 2018-08-03 | 张鸿 | 一种用于治疗鼻炎的吸入性粉剂及其制备方法 |
-
2012
- 2012-09-26 CN CN2012103618721A patent/CN102824626A/zh active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103495144A (zh) * | 2013-10-12 | 2014-01-08 | 龚卫新 | 一种治疗过敏性鼻炎药剂 |
| CN106110248A (zh) * | 2016-07-15 | 2016-11-16 | 杨小玲 | 一种专治感冒、鼻炎的中草药 |
| CN107114795A (zh) * | 2017-07-06 | 2017-09-01 | 胥永贵 | 一种弱碱补钙、苏打碱化姜制剂及其制备方法和应用 |
| CN108355051A (zh) * | 2018-05-23 | 2018-08-03 | 张鸿 | 一种用于治疗鼻炎的吸入性粉剂及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20110073717A (ko) | 기능성 식품 및 이의 제조방법 | |
| CN104322617A (zh) | 一种辅助降血糖的饼干及其制备方法 | |
| KR101202988B1 (ko) | 건강 약차 및 그 제조방법 | |
| CN102113599B (zh) | 一种杜仲金银花茶及其制作方法 | |
| CN103417820B (zh) | 用于排解烟毒、康复机能、减烟控烟的中药制品及其制备方法 | |
| CN103239662A (zh) | 兽用驱虫中药制剂 | |
| CN102824626A (zh) | 一种治疗过敏性鼻炎的药合泡剂及其制备方法 | |
| KR101826737B1 (ko) | 생약재 추출물을 유효성분으로 하는 근육틱 및 우울증 개선용 조성물 및 그의 제조방법 | |
| KR20130122834A (ko) | 총백을 이용한 기능성 한방차 및 그 제조방법 | |
| CN109077167A (zh) | 一种祛湿茶及其制备方法 | |
| CN105125997A (zh) | 一种解酒茶及其制备方法 | |
| CN103908592A (zh) | 一种解毒的中药及其制备方法 | |
| CN104161248B (zh) | 一种能治疗湿热泄泻的药品和食品 | |
| CN103417886B (zh) | 一种治疗支气管哮喘的中药组合物及其制备方法 | |
| CN106262756A (zh) | 干菜花生米辣椒酱及其制备方法 | |
| CN109453317A (zh) | 一种用于滋补强壮的蒙药及其制备工艺 | |
| CN109984342B (zh) | 一种药膳及其制备方法 | |
| CN114748583A (zh) | 一种滋补养生的中药药酒 | |
| CN103845540A (zh) | 一种纯中药戒毒胶囊及其制备方法 | |
| CN103798472A (zh) | 一种保健茶及保健养生制剂 | |
| CN107549535A (zh) | 一种甘草醒酒植物饮料及其制备方法 | |
| CN103495144A (zh) | 一种治疗过敏性鼻炎药剂 | |
| CN103301314B (zh) | 一种治疗内脏排毒的药物以及制备方法 | |
| CN104887885A (zh) | 治疗哮喘的中药 | |
| CN104322752A (zh) | 一种止咳化痰保健绿茶 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20121219 |